Segments - Saudi Arabia Neurology Devices Market by Diagnostic and Types (Neurosurgery Devices [Stereotactic Systems, Neuroendoscopes, Aneurysm Clips, and Others], Neurostimulation Devices [Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Spinal Cord Stimulation Devices, and Others], Cerebrospinal Fluid Management Devices, Interventional Neurology Devices [Embolic Coils, Interventional/Surgical Simulators, Carotid Artery Stents, Support Devices, and Neurothrombectomy Devices], and Others), and Country - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The Saudi Arabia neurology devices market size is expected to register at a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the rising number of neurovascular disease patients and increasing demand for neurology devices.
Neurological devices are the device that aid in diagnosis, prevention, and treatment of variety of neurological disorders. The most prevalent conditions that utilize the neurology devices are alzheimer disease, major depression, prkinson disease, epilepsy, spinal cord injury, and traumatic brain injury. The neurological devices can be used for restoring the hearing and eye-sight. Apart from hearing and vision, the neurological devices are useful for increasing the function associated with limb loss and congenital limb differences. The most commonly used neurological devices include neurodiagnostics, neurointerventional, and neurostimulation devices. The cerebrospinal fluid management devices include valves, shunts, and external drainage systems to maintain the flow of cerebrospinal fluid and assist in draining the excess fluid out from the brain. The shunt offers an alternative fluid pathway for the cerebrospinal fluid drains out. The bypass that is created with the help of the stent aids in relieving the excess fluid buildup. Furthermore, various other instruments or devices are available in the market such as catheters, stents, ultrasonic aspirators, and stereotactic systems are widely used for the treatment of neurological diseases.
The COVID-19 pandemic has affected almost every industry including the healthcare industry. The stringent regulations and implication of nation-wide lockdowns made it challenging for the neurovascular disease patients to reach the hospitals. Therefore, the number of patient visits to hospitals was reduced significantly. The outbreak of coronavirus disease resulted into disruption in supply chains, manufacturing processes, transportation, and research & development activities. The reduction in the recruitments for clinical trials had further restricted the overall growth of the neurology devices market in the year 2020.
The report on the Saudi Arabia neurology devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Neurology Devices Market - Saudi Arabia Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2020 |
Historic Data |
2018–2019 |
Forecast Period |
2021–2028 |
Segmentation |
Types (Neurosurgery Devices [Stereotactic Systems, Neuroendoscopes, Aneurysm Clips, and Others], Neurostimulation Devices [Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Spinal Cord Stimulation Devices, and Others], Cerebrospinal Fluid Management Devices, Interventional Neurology Devices [Embolic Coils, Interventional/Surgical Simulators, Carotid Artery Stents, Support Devices, and Neurothrombectomy Devices], and Others) |
Country |
Saudi Arabia |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Medtronic PLC; Stryker Corporation; Siemens Healthineers; Nihon Kohden Corporation; and Abbott Laboratories |
On the basis of types, the market is segregated into neurosurgery devices, neurostimulation devices, cerebrospinal fluid management devices, interventional neurology devices, and others. The neurosurgery devices segment is further categorized as stereotactic systems, neuroendoscopes, aneurysm clips, and others. The neurostimulation devices segment is segmented into deep brain stimulation devices, sacral nerve stimulation devices, spinal cord stimulation devices, and others. The interventional neurology devices segment is further classified as embolic coils, interventional/surgical simulators, carotid artery stents, support devices, and neurothrombectomy devices. The neurostimulation devices segment is expected to expand at a significant CAGR during the forecast period owing to the increasing use of the sacral nerve stimulation devices and deep brain stimulation devices. Moreover, rising prevalence of neuropsychiatric disorders is expected to promote the expansion of the market segment in the coming years. Furthermore, the increasing incidence of parkinson's disease, chronic pain, essential tremor, dystonia, major depression, and obsessive-compulsive disorder is anticipated to grow the market segment at a robust rate during the projected period.
On the other hand, the interventional neurology devices segment is expected to boost the growth of the market segment during the forecast period due to the increasing hospitalization of neurovascular disease patients, ongoing product development, and expansion of healthcare infrastructure. Furthermore, the increasing commercialization and availability of favorable medical reimbursements is projected to boost the expansion of the market segment in the coming years.
The key players competing in the Saudi Arabia neurology devices market are Medtronic PLC; Stryker Corporation; Siemens Healthineers; Nihon Kohden Corporation; and Abbott Laboratories. The Companies are engaging in vigorous acquisitions, collaborations, and ventures to consolidate their position in the market.
In November 2021, Medtronic PLC planned to set up a global research & development center involving an investment of around USD 159 million in Hyderabad, India.The initiative facilitated the research work for medical products to treat over 70 health conditions that include cardiac devices, cranial & spine robotics, surgical tools, insulin pumps, patient monitoring systems, and others.